FMP

FMP

Enter

ERGO - Entia Biosciences, I...

Financial Summary of Entia Biosciences, Inc.(ERGO), Entia Biosciences, Inc. engages in the development, production, and distribution of dietary suppleme

photo-url-https://financialmodelingprep.com/image-stock/ERGO.png

Entia Biosciences, Inc.

ERGO

PNK

Inactive Equity

Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc. offers its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon.

0.0001 USD

0 (0%)

About

ceo

Mr. Timothy A. Timmins

sector

Healthcare

industry

Biotechnology

website

https://www.entiabio.com

exchange

PNK

Description

Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as...

CIK

N/A

ISIN

US29384E1047

CUSIP

29384E104

Address

13565 SW Tualatin-Sherwood Roa...

Phone

971-228-0709

Country

US

Employee

6

IPO Date

Jan 18, 2008

Summary

CIK

-

Exchange

PNK

Industry

Biotechnology

Sector

Healthcare

CUSIP

29384E104

ISIN

US29384E1047

Country

US

Price

0

Beta

11.41

Volume Avg.

6

Market Cap

235.63k

Shares

-

52-Week

2.0E-4-0.0318

DCF

0

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-

P/B

-

Website

https://www.entiabio.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest ERGO News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep